USE OF CGRP ANTAGONISTS IN TREATMENT AND PREVENTION OF HOT FLUSHES IN PROSTATE CANCER PATIENTS

Title:

USE OF CGRP ANTAGONISTS IN TREATMENT AND PREVENTION OF HOT FLUSHES IN PROSTATE CANCER PATIENTS

Document Type and Number:

WIPO Patent Application WO2006069754

Kind Code:

A9

Abstract:

The invention relates to a method of treatment or prevention of hot flushes in men who underwent castration, e.g. due to androgen ablation treatment in prostate cancer therapy, comprising administration of an effective amount of a selected CGRP antagonist to the patient, and to the use of said active compounds for the manufacture of a pharmaceutical composition intended to be used in this method.

More Like This:

JP2002530333	INDUSTRIAL APPLICABILITY The use of N-substituted 3-azabicycloalkane derivative for producing a therapeutic agent for central nervous system disorders.
JPS5738781	QUINAZOLINE COMPOUND
JP6992284	Pharmaceutical composition containing dihydroindridinone derivative

Inventors:

RUDOLF KLAUS (DE)
DOODS HENRI (DE)
MUELLER STEPHAN GEORG (DE)
ZAMPONI ANNETTE (DE)
LUSTENBERGER PHILIPP (CH)
STENKAMP DIRK (DE)
ARNDT KIRSTEN (DE)
SCHAENZLE GERHARD (DE)
BRICKL ROLF-STEFAN (DE)

Application Number:

PCT/EP2005/013974

Publication Date:

August 09, 2007

Filing Date:

December 23, 2005

Export Citation:

Click for automatic bibliography generation Help

Assignee:

BOEHRINGER INGELHEIM INT (DE)
BOEHRINGER INGELHEIM PHARMA (DE)
RUDOLF KLAUS (DE)
DOODS HENRI (DE)
MUELLER STEPHAN GEORG (DE)
ZAMPONI ANNETTE (DE)
LUSTENBERGER PHILIPP (CH)
STENKAMP DIRK (DE)
ARNDT KIRSTEN (DE)
SCHAENZLE GERHARD (DE)
BRICKL ROLF-STEFAN (DE)

International Classes:

A61K31/517

Download PDF:

View/Download PDF PDF Help

Previous Patent: DEVICE AND METHOD FOR THE LOCALLY RESOLVED CHEMICAL STIMULATION

Next Patent: LENS MODULE COMPRISING AT LEAST ONE REPLACEABLE OPTICAL ELEMENT